According to the results of a trial in 42 countries, a drug therapy appears to reduce lung function loss in patients with moderate to severe chronic obstructive pulmonary disease (COPD).

Adverse drug reactions (ADRs) remain a common clinical problem since they can mimic many diseases and cause significant morbidity and mortality. Judicious prescribing is important to minimize ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, drug interactions ... in the treatment of patients with COPD who require daily bronchodilator treatment.

Elevated CAR has been associated with adverse outcomes in many conditions, including cancer, sepsis, COVID-19, and cardiovascular diseases. A higher C-reactive protein to albumin ratio (CAR) is ...